MONASH University Faculty of Pharmacy and Pharmaceutical Sciences has announced it will be offering a new doctoral program from next year, aiming to build upon world-leading research that has given the university its global high profile (PD 16 Sep 16).
Six members of the faculty have been named as Thomson-Reuters Highly Cited Researchers, ranking the faculty as number one worldwide, while it ranked fourth in the world for Pharmacy and Pharmacology in the 2016 QS World Rankings by Subject.
Faculty of Pharmacy and Pharmaceutical Sciences Dean Professor Bill Charman explained, "The new program will equip our graduates for a competitive and globalised future."
"We recognise that PhD graduates are in demand from a wide range of employers (eg. multi-national companies, SME companies, start-up ventures, academia and research institutes, and various other sectors) that value an integrated and comprehensive contemporary doctoral program."
The Monash PhD candidatures will include a supervised research project of three to four year duration as well as the Monash Doctoral Program Training Course, which ensures students are equipped with the requisite research and communication skills to succeed in their project.
In addition, the Faculty's enhanced program now offers students two other key components: an advanced course in drug discovery and development and one of a range of four other additional research experiences.
"We believe that the flexibility and added value incorporated in this new structure, combined with the high impact of the research we conduct, will create a world-class research and training experience for all our PhD students -- who are the next generation of our scientific leaders and researchers," said Charman.
Visit www.monash.edu for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Sep 16
